P2RX1 and non-small cell lung carcinoma: Zhang et al. (2024) found that P2RX1-deficient neutrophils contributed to immunosuppressive effects in non-small-cell lung cancer (NSCLC), suggesting that P2RX1 could be a potential target to counteract the immunosuppressive activity of neutrophils [142].